Safety of sugammadex for myasthaenia gravis patients undergoing general anaesthesia: a retrospective database study

Safety of sugammadex for myasthaenia gravis patients undergoing general anaesthesia: a retrospective database study

Background: Using neuromuscular blocking drugs (NMBDs) for patients with myasthaenia gravis remains a challenge in perioperative management. Sugammadex has enabled the safe use of NMBDs. We investigated whether the adverse outcomes, and the treatment used for myasthaenic crises and tracheotomy, are...

Full description

Bibliographic Details
Main Authors: Isao Nahara, Masato Takeuchi, Hiroshi Yonekura, Chikashi Takeda, Koji Kawakami
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:BJA Open
Subjects:
autoimmune disease
general anaesthesia
myasthaenia gravis
neuromuscular blocking drugs
neuromuscular disease
rocuronium
Online Access:http://www.sciencedirect.com/science/article/pii/S2772609622000910

Similar Items

Similar Items